medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2023, Number 2

<< Back Next >>

Cir Plast 2023; 33 (2)

Treatment levels of galactorrhea in breast augmentation with implants: a rare condition with high-impact risk

Ortiz-López JB, Martínez-Mosqueira JR, Vázquez-Armenta MG

Language: Spanish
References: 18
Page: 73-80
PDF size: 471.58 Kb.


ABSTRACT

Breast augmentation was the most performed aesthetic surgical procedure worldwide according to statistics of the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020. Galactorrhea is a rare complication after breast augmentation with implants, with an incidence of 0.96% and only thirty-eight cases reported in the most recent systematic review in 2021, although with highly significant short and long-term possible consequences. Predisposing factors such as: use of oral contraceptives, psychological stress, use of anti-dopaminergic drugs, approach by periareolar incision and placement of the breast implant in the sub glandular plane have been evidenced. In the period of 5 years (2015-2020) in our clinic in Mexico City we evidenced galactorrhea/galactocele after the placement of breast implants in seven patients (incidence of 0.31%), which required a more complex diagnostic strategy and pharmacological/surgical treatment, which is why we reviewed our own cases and the literature. With the information available, the existing evidence, and our experience, we put forward a guideline for the effective determination of preoperative risk factors, a complete diagnostic approach and effective therapeutic levels to reduce the possible short and long-term complications of galactorrhea/galactocele associated with breast augmentation with implants.


REFERENCES

  1. ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2020; Available in: https://www.isaps.org/media/hprkl132/isaps-global-survey_2020.pdf

  2. Basile FV, Basile AR. Diagnosis and management of galactorrhea after breast augmentation. Plast Reconstr Surg 2015; 135 (5): 1349-1356.

  3. Adams WP. The process of breast augmentation: four sequential steps for optimizing outcomes for patients. Plast Reconstr Surg 2008; 122: 1892-1900.

  4. Adams WP Jr, Culbertson EJ, Deva AK et al. Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg 2017; 140 (3): 427-431.

  5. Doridot V, Audibert F. Galactorrea. EMC-Tratado de medicina 2002; 6 (3): 1.

  6. Sharma SC, Basu NN. Galactorrhea/galactocele after breast augmentation: a systematic review. Ann Plast Surg 2021; 86: 115-120.

  7. EI-Hassan ND, Zaworski RE, Castro A, LeMaire WJ. Serum prolactin levels following augmentation mammaplasty. Plast Reconstr Surg 1981; 68: 215-217.

  8. Caputy GG, Flowers RS. Copious lactation following augmentation mammaplasty: an uncommon but not rare condition. Aesthetic Plast Surg 1994; 18: 393-397.

  9. Crosignani PG. Current treatment issues in female hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol 2006; 125 (2):152-164.

  10. Collado MC, Delgado S, Maldonado A et al. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Letters in Applied Microbiology 2009; 48: 523-528.

  11. Simao TS. Galactorrhea and galactocele after breast augmentation: diagnosis and treatment algorithm. Plast Reconstr Surg 2021; 147 (5): 915e-916e.

  12. Fidalgo RFT. Galactorrea grave tras aumento mamario con implantes. Cir Plast Iberolatinoam 2012; 38 (2): 169-175.

  13. Wang Y, Tian J, Lui J. Suppressive effect of leukotriene antagonists on capsular contracture in patients who underwent breast surgery with prosthesis: a meta-analysis. Plast Reconstr Surg 2020; 145: 901-911.

  14. Hu H, Jacombs A, Vickery K, Merten SL, Pennington D., Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015; 135: 319-329.

  15. Alex A, Bhandary E, McGuire KP. Anatomy and physiology of the breast during pregnancy and lactation. Adv Exp Med Biol 2020; 1252: 3-7.

  16. Melmed S, Casanueva FF, Hoffman AR et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Meta 2011; 96 (2): 273-288.

  17. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 2013; 60 (1): 49-74.

  18. Collado M.C., Delgado S, Maldonado A et al. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Lett Appl Microbiol 2009; 48: 523-528.




2020     |     www.medigraphic.com